If you need an incentive to wise up and get money smart, read this because you’d never want anyone you care about, including yourself, to be dependent on government aged care services.
If you need an incentive to wise up and get money smart, read this because you’d never want anyone you care about, including yourself, to be dependent on government aged care services.
Here are two ETFs that allow you to jump on the robotics, automation and AI bandwagon.
Here are two stocks that could be impacted by the end of physical catalogues and “junk mail”.
The Tasmanian Government has a prominent economist dancing with the devil, exhuming death taxes and pushing payroll tax onto more small businesses. And it’s thought this could be a model for the rest of the country?
Former PM Paul Keating has a big idea to help prevent Aussies from being dumped in nursing homes. Will this one be a hard ‘political’ sell?
The major supermarkets are keen to push their rewards programs onto shoppers, but who really benefits – the customer or the retailer?
Catch up on the latest market and economic news from Australia and around the world.
Why are these standout names so good at what they do? Do they have a hedgehog in common?
As NAB and CommBank zip into buy now, pay later products, what could happen to the share prices of these two tech stars?
When great minds collide, magical things can happen. Here’s an example of a meeting point of three market experts on one share that has potential to shine!
In a rare tame week for key economic data it is Thursday’s job figures that clearly stands out.
We look at two stocks in the IIR Pharma & Biotech Index that were the best performers in the top 10, both increasing over 40% for the month on the back of promising developments for their respective products.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox